From the Guidelines
No, IVER (Infantile Vascular Embryonic Remodeling) is not a recognized standard abbreviation for any specific type of hemangioma in medical literature or clinical practice. The standard terminology for infantile hemangiomas includes classifications such as superficial, deep, mixed, or segmental hemangiomas, as discussed in the clinical practice guideline for the management of infantile hemangiomas 1. These classifications are based on the depth and distribution of the vascular lesions. Infantile hemangiomas are typically described by their clinical appearance, anatomical location, and growth characteristics rather than by an acronym like IVER.
Medical professionals use the International Society for the Study of Vascular Anomalies (ISSVA) classification system to categorize vascular anomalies, including hemangiomas, which does not include the term IVER. The diagnosis and management of infantile hemangioma, as outlined in the Pediatrics journal 1, also do not recognize IVER as a standard abbreviation. Furthermore, the British Society for Paediatric Dermatology consensus guidelines for the treatment of proliferating infantile haemangiomas with oral propranolol 1 do not mention IVER as a relevant term in the context of hemangioma classification or treatment.
When discussing hemangiomas with healthcare providers, it's essential to use standardized terminology to ensure clear communication about diagnosis and treatment options. The use of standardized terminology is crucial in clinical practice, as highlighted by the clinical practice guideline for the management of infantile hemangiomas 1, to provide optimal care for patients with infantile hemangiomas.
From the Research
Types of Hemangiomas
- There is no mention of IVER (Infantile Vascular Embryonic Remodeling) being a recognized standard abbreviation for any specific type of hemangioma in the provided studies 2, 3, 4, 5, 6.
Hemangioma Treatment
- The studies discuss various treatments for hemangiomas, including propranolol 2, 4, 5, 6, systemic corticosteroids 3, 4, 5, and other therapies like vincristine and bevacizumab 6.